Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
paromomycin (humatin) (1 trial)
Leishmaniasis (Phase 4)
Leishmaniasis, Visceral (Phase 4)
Trials (1 total)
Trial APIs (1 total)